Citation Impact
Citing Papers
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Depression
2018 Standout
Drug Interactions with Grapefruit Juice
1997
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Fluoxetine, a selective inhibitor of serotonin uptake
1991
The role of individual human cytochrpmes P450 in drug metabolism and clinical response
1992
Effects of Guanine, Inosine, and Xanthine Nucleotides on β2-Adrenergic Receptor/GsInteractions: Evidence for Multiple Receptor Conformations
1999 StandoutNobel
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes
1999
Evolving concepts of partial agonism
1992
Fluorescent Labeling of Purified β2 Adrenergic Receptor
1995 StandoutNobel
Novel Oral Drug Formulations
1994
Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin
2003
Effect of a Chemical Delivery System for Dexamethasone (Dex-CDS) on Peritumoral Edema in an Experimental Brain Tumor Model
1997
Cytochrome P450-mediated metabolism in the human gut wall
2009
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Organoid Models and Applications in Biomedical Research
2015 Standout
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Dopaminergic influences on formation of a motor memory
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
1998
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review
2004
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
New Equations to Estimate GFR in Children with CKD
2009 Standout
Drug–Grapefruit Juice Interactions
2000
G Protein-coupled Receptors
1998 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Adrenergic receptor signal transduction and regulation
1995 StandoutNobel
Pharmacotherapy of Raynaudʼs Phenomenon
1996
The biochemistry and medical significance of the flavonoids
2002 Standout
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
2002
Musical Training as a Framework for Brain Plasticity: Behavior, Function, and Structure
2012 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
Drug Interactions with Grapefruit Juice
1998
Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4
1999
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice
1993
Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans.
2000
The effects of cisapride on plasma L ‐dopa levels and clinical response in Parkinson's disease
1995
Gastric emptying time and gastric motility in patients with Parkinson's disease
2001
Predicting GFR in children and adults: A comparison of the Cockcroft-Gault, Schwartz, and Modification of Diet in Renal Disease formulas
2003
CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5′-promoter region polymorphism
2000
Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men
1997
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2Double Knockout Mice
2000 StandoutNobel
Exclusion of Elderly Subjects From Clinical Trials for Parkinson Disease
1997
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
Grapefruit juice–drug interactions
1998
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors
2000
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
Long‐Term Survival and Use of Antihypertensive Medications in Older Persons
1995
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
1995 Standout
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
2010
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Structural Instability of a Constitutively Active G Protein-coupled Receptor
1997 StandoutNobel
Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
2000
Calcium Antagonists in the Elderly
1996
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Inverse agonist activity of beta-adrenergic antagonists.
1994
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Fluoxetine versus other types of pharmacotherapy for depression
2013
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
Cyclodextrin Drug Carrier Systems
1998 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.
1997
Cytochrome P450-mediated metabolism in the human gut wall
2009
Functional Differences between Full and Partial Agonists: Evidence for Ligand-Specific Receptor Conformations
2001 StandoutNobel
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Effects of Guanine, Inosine, and Xanthine Nucleotides on β2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations
1999 StandoutNobel
The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.
1993
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
1999
Different Effects of Gsα Splice Variants on β2-Adrenoreceptor-mediated Signaling
1998 StandoutNobel
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
2009 StandoutNobel
Different Effects of Gsα Splice Variants on β2-Adrenoreceptor-mediated Signaling
1998 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Pharmacokinetic and Pharmacodynamic Changes in the Elderly
1998
Industry sponsorship and research outcome
2017 Standout
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
1999
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of DG Waller being referenced
The first pass metabolism of nifedipine in man.
1984
The pharmacokinetics of oral nifedipine‐a population study.
1988
Prodrugs.
1989
Ethnic differences in the pharmacokinetics of oral nifedipine.
1991
Beta‐adrenoceptor partial agonists: a renaissance in cardiovascular therapy?
1990
Factors affecting the absolute bioavailability of nifedipine.
1995
Clinical and rheological effects of nifedipine in Raynaud's phenomenon.
1986
Age‐related changes in the pharmacokinetics and pharmacodynamics of nifedipine.
1988
Measurement of glomerular function during cisplatin therapy.
1991
The influence of levodopa on gastric emptying in man.
1990
The influence of posture on the pharmacokinetics of orally administered nifedipine.
1992
The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.
1991
The trans‐hepatic extraction of nifedipine.
1987
The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.
1989
Comparative effects of fluoxetine and amitriptyline on cardiac function.
1988